Study of high dose toremifene for metastatic breast cancer after failure of adjuvant therapy of aromatase inhibitor.
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2011
At a glance
- Drugs Toremifene (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 06 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Oct 2006 The expected completion date for this trial is now 1 Aug 2009.